Amarin - 33 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits and dividends. The latest closing stock price for Amarin as of February 13, 2026 is 14.74.

The all-time high Amarin stock closing price was 27500.00 on July 09, 1993.
The Amarin 52-week high stock price is 20.90, which is 41.8% above the current share price.
The Amarin 52-week low stock price is 7.00, which is 52.5% below the current share price.
The average Amarin stock price for the last 52 weeks is 13.98.

Amarin Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	15.0253	13.7200	16.5100	13.5000	14.7400	5.59%
2025	13.5259	10.4000	20.2500	8.0000	13.9600	42.45%
2024	15.5571	17.8000	27.0000	8.8000	9.8000	-43.68%
2023	24.4864	23.8000	43.8000	13.2000	17.4000	-28.10%
2022	39.8223	70.2000	74.6000	21.4000	24.2000	-64.09%
2021	103.0905	100.6000	176.0000	64.8000	67.4000	-31.08%
2020	170.3802	430.6000	430.6000	72.8000	97.8000	-77.19%
2019	364.1571	260.2000	482.4000	252.2000	428.8000	57.53%
2018	144.3060	84.8000	459.6000	49.0000	272.2000	239.40%
2017	66.3665	61.8000	85.8000	57.4000	80.2000	30.19%
2016	46.8524	36.2000	69.4000	25.4000	61.6000	62.96%
2015	40.1444	22.6000	58.0000	20.0000	37.8000	92.86%
2014	30.3952	39.2000	48.0000	16.6000	19.6000	-50.25%
2013	118.1913	162.0000	183.2000	28.0000	39.4000	-75.65%
2012	221.6416	141.0000	309.2000	127.0000	161.8000	8.01%
2011	214.0810	166.6000	390.0000	120.6000	149.8000	-8.66%
2010	53.0810	27.6000	169.8000	19.6000	164.0000	473.43%
2009	23.8532	13.6000	39.0000	10.4000	28.6000	101.41%
2008	38.0245	50.0000	71.8000	12.0000	14.2000	-72.69%
2007	200.2550	436.0000	756.0000	46.0000	52.0000	-88.60%
2006	522.9402	270.0000	748.0000	254.0000	456.0000	90.00%
2005	358.4365	524.0000	680.0000	212.0000	240.0000	-55.72%
2004	277.9286	308.0000	798.0000	106.0000	542.0000	75.97%
2003	580.2778	788.0000	962.0000	278.0000	308.0000	-61.40%
2002	1681.3175	3420.0000	4200.0000	552.0000	798.0000	-77.03%
2001	2655.0358	1100.0000	5594.0000	1000.0000	3474.0000	215.82%
2000	1195.6349	900.0000	1556.2500	750.0000	1100.0000	15.79%
1999	1408.1349	887.5000	2275.0000	825.0000	950.0000	33.33%
1998	2068.5020	6125.0000	6125.0000	200.0000	712.5000	-88.60%
1997	10047.1838	11625.0000	13250.0000	5875.0000	6250.0000	-46.24%
1996	16968.1350	18000.0000	22500.0000	11000.0000	11625.0000	-35.42%
1995	14550.3472	13000.0000	20000.0000	10000.0000	18000.0000	38.46%
1994	15457.9623	17500.0000	21000.0000	9625.0000	13000.0000	-25.71%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$0.309B	$0.229B
Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels. The FDA approved Vascepa to reduce cardiovascular risk in patients with persistent elevated triglycerides on statin therapy for LDL-C. The drug received approval for both indications in Europe under the tradename of Vazkepa. It has initiated various promotional activities and direct-to-consumer programs as well as expanded its salesforce to support promotion of Vascepa's expanded label. A generic version of Vascepa has been launched for elevated TG levels.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$317.192B	25.25
Amgen (AMGN)	United States	$197.192B	16.76
Gilead Sciences (GILD)	United States	$188.348B	18.63
Bristol Myers Squibb (BMY)	United States	$121.903B	9.73
GSK (GSK)	United Kingdom	$119.328B	12.95
Vertex Pharmaceuticals (VRTX)	United States	$117.984B	28.32
Regeneron Pharmaceuticals (REGN)	United States	$82.361B	21.72
CSL (CSLLY)	Australia	$52.484B	0.00
Argenex SE (ARGX)	Netherlands	$51.582B	63.73
Alnylam Pharmaceuticals (ALNY)	United States	$40.754B	181.46
Insmed (INSM)	United States	$31.174B	0.00
Biogen (BIIB)	United States	$28.691B	12.79
Royalty Pharma (RPRX)	United States	$25.860B	9.28
BioNTech SE (BNTX)	Germany	$23.815B	0.00
Incyte (INCY)	United States	$20.051B	17.40
Exact Sciences (EXAS)	United States	$19.697B	543.32
Genmab (GMAB)	Denmark	$19.008B	14.30
Revolution Medicines (RVMD)	United States	$18.816B	0.00
Roivant Sciences (ROIV)	United Kingdom	$18.604B	0.00
Illumina (ILMN)	United States	$17.486B	23.60
Sino Biopharmaceutical (SBMFF)	Hong Kong, SAR China	$15.757B	0.00
Moderna (MRNA)	United States	$15.672B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$14.350B	0.00
Ascendis Pharma (ASND)	Denmark	$13.517B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	21.26
Guardant Health (GH)	United States	$12.952B	0.00
BioMarin Pharmaceutical (BMRN)	United States	$11.515B	20.89
Avidity Biosciences (RNA)	United States	$11.282B	0.00
Exelixis (EXEL)	United States	$11.090B	15.64
QIAGEN (QGEN)	Netherlands	$10.738B	20.57
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.105B	39.40
Abivax SA (ABVX)	France	$9.769B	0.00
Bio-Techne Corp (TECH)	United States	$9.315B	33.83
Axsome Therapeutics (AXSM)	United States	$9.222B	0.00
Halozyme Therapeutics (HALO)	United States	$9.046B	14.46
Arrowhead Pharmaceuticals (ARWR)	United States	$8.735B	40.77
Praxis Precision Medicines (PRAX)	United States	$8.388B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$7.959B	29.74
Cytokinetics (CYTK)	United States	$7.952B	0.00
Krystal Biotech (KRYS)	United States	$7.837B	40.52
Repligen (RGEN)	United States	$7.466B	79.90
Nuvalent (NUVL)	United States	$7.367B	0.00
Vaxcyte (PCVX)	United States	$7.193B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
Belite Bio (BLTE)	United States	$6.550B	0.00
ImmunityBio (IBRX)	United States	$6.520B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.411B	0.00
Kymera Therapeutics (KYMR)	United States	$6.045B	0.00
PTC Therapeutics (PTCT)	United States	$5.676B	7.71
Alkermes (ALKS)	Ireland	$5.497B	16.16
Mirum Pharmaceuticals (MIRM)	United States	$5.243B	0.00
Cogent Biosciences (COGT)	United States	$5.228B	0.00
Immunovant (IMVT)	United States	$5.219B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.122B	132.15
Celcuity (CELC)	United States	$4.852B	0.00
Scholar Rock Holding (SRRK)	United States	$4.760B	0.00
Apogee Therapeutics (APGE)	United States	$4.735B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$4.663B	0.00
Zealand Pharma (ZLDPF)	Denmark	$4.534B	4.59
TG Therapeutics (TGTX)	United States	$4.512B	10.22
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Amicus Therapeutics (FOLD)	United States	$4.498B	358.25
Structure Therapeutics (GPCR)	United States	$4.371B	0.00
CG Oncology (CGON)	United States	$4.164B	0.00
Arcellx (ACLX)	United States	$3.970B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.917B	0.00
Erasca (ERAS)	United States	$3.811B	0.00
GRAIL (GRAL)	United States	$3.738B	0.00
ADMA Biologics Inc (ADMA)	United States	$3.710B	26.42
ACADIA Pharmaceuticals (ACAD)	United States	$3.656B	30.87
Anbio Biotechnology (NNNN)	Germany	$3.630B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.575B	87.75
Viking Therapeutics (VKTX)	United States	$3.523B	0.00
Liquidia (LQDA)	United States	$3.396B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.389B	99.36
Legend Biotech (LEGN)	United States	$3.335B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.272B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.216B	0.00
Edgewise Therapeutics (EWTX)	United States	$3.215B	0.00
Vera Therapeutics (VERA)	United States	$2.958B	0.00
Twist Bioscience (TWST)	United States	$2.922B	0.00
Denali Therapeutics (DNLI)	United States	$2.813B	0.00
Alumis (ALMS)	United States	$2.798B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.790B	71.13
IDEAYA Biosciences (IDYA)	United States	$2.763B	0.00
Viridian Therapeutics (VRDN)	United States	$2.744B	0.00
Travere Therapeutics (TVTX)	United States	$2.738B	0.00
Beam Therapeutics (BEAM)	United States	$2.733B	0.00
Disc Medicine (IRON)	United States	$2.705B	0.00
Spyre Therapeutics (SYRE)	United States	$2.703B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$2.685B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.573B	0.00
Immunome (IMNM)	United States	$2.476B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.412B	6.55
Adaptive Biotechnologies (ADPT)	United States	$2.372B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.267B	0.00
Maze Therapeutics (MAZE)	United States	$2.264B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.205B	0.00
Mesoblast (MESO)	Australia	$2.179B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.178B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.165B	0.00
Arcus Biosciences (RCUS)	United States	$2.155B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.140B	0.00
Zai Lab (ZLAB)	China	$2.102B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.065B	11.27
Dianthus Therapeutics (DNTH)	United States	$2.052B	0.00
Nuvation Bio (NUVB)	United States	$1.985B	0.00
Recursion Pharmaceuticals (RXRX)	United States	$1.861B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.837B	0.00
Sarepta Therapeutics (SRPT)	United States	$1.823B	0.00
Stoke Therapeutics (STOK)	United States	$1.821B	47.60
Dynavax Technologies (DVAX)	United States	$1.819B	53.41
Zymeworks (ZYME)	United States	$1.734B	0.00
MannKind (MNKD)	United States	$1.729B	56.30
ANI Pharmaceuticals (ANIP)	United States	$1.723B	13.36
Vericel (VCEL)	United States	$1.718B	141.54
Tango Therapeutics (TNGX)	United States	$1.706B	0.00
MBX Biosciences (MBX)	United States	$1.706B	0.00
Sionna Therapeutics (SION)	United States	$1.680B	0.00
Precigen (PGEN)	United States	$1.677B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.637B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.631B	0.00
Nurix Therapeutics (NRIX)	United States	$1.618B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.606B	0.00
Rapt Therapeutics (RAPT)	United States	$1.602B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.571B	0.00
Celldex Therapeutics (CLDX)	United States	$1.566B	0.00
Tyra Biosciences (TYRA)	United States	$1.558B	0.00
AnaptysBio (ANAB)	United States	$1.520B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.495B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
NeoGenomics (NEO)	United States	$1.445B	0.00
Alvotech (ALVO)	Luxembourg	$1.420B	20.48
NovoCure (NVCR)	Jersey	$1.403B	0.00
Trevi Therapeutics (TRVI)	United States	$1.403B	0.00
Zenas BioPharma (ZBIO)	United States	$1.402B	0.00
UniQure (QURE)	Netherlands	$1.393B	0.00
Novavax (NVAX)	United States	$1.368B	3.48
Intellia Therapeutics (NTLA)	United States	$1.346B	0.00
Rapport Therapeutics (RAPP)	United States	$1.333B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.300B	0.00
Biohaven (BHVN)	United States	$1.217B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.205B	57.81
Immatics (IMTX)	Germany	$1.203B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.202B	0.00
Inhibrx Biosciences (INBX)	United States	$1.194B	0.00
Nanobiotix S.A - (NBTX)	France	$1.185B	0.00
Kodiak Sciences (KOD)	United States	$1.167B	0.00
Septerna (SEPN)	United States	$1.153B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.129B	0.00
Compass Therapeutics (CMPX)	United States	$1.128B	0.00
EyePoint (EYPT)	United States	$1.077B	0.00
Pharming Group (PHAR)	Netherlands	$1.073B	0.00
Vir Biotechnology (VIR)	United States	$1.073B	0.00
Certara (CERT)	United States	$1.062B	19.62
Geron (GERN)	United States	$1.041B	0.00
Sana Biotechnology (SANA)	United States	$1.010B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.003B	0.00
Iovance Biotherapeutics (IOVA)	United States	$1.000B	0.00
Ventyx Biosciences (VTYX)	United States	$1.000B	0.00
Oric Pharmaceuticals (ORIC)	United States	$0.997B	0.00
Palvella Therapeutics (PVLA)	United States	$0.971B	0.00
Fortrea Holdings (FTRE)	United States	$0.949B	20.14
Urogen Pharma (URGN)	United States	$0.946B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.935B	0.00
Castle Biosciences (CSTL)	United States	$0.931B	127.60
CureVac (CVAC)	Germany	$0.927B	0.00
ArriVent BioPharma (AVBP)	United States	$0.926B	0.00
Pacira BioSciences (PCRX)	United States	$0.923B	10.57
CytomX Therapeutics (CTMX)	United States	$0.920B	13.57
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.913B	0.00
Inventiva S.A (IVA)	France	$0.905B	0.00
AbCellera Biologics (ABCL)	Canada	$0.880B	0.00
Evommune (EVMN)	United States	$0.879B	0.00
DBV Technologies S.A (DBVT)	France	$0.871B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$0.858B	0.00
Janux Therapeutics (JANX)	United States	$0.790B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.784B	0.00
MapLight Therapeutics (MPLT)	United States	$0.781B	0.00
GH Research (GHRS)	Ireland	$0.781B	0.00
Arbutus Biopharma (ABUS)	United States	$0.771B	0.00
Bicara Therapeutics (BCAX)	United States	$0.770B	0.00
Arvinas (ARVN)	United States	$0.760B	0.00
MiMedx (MDXG)	United States	$0.754B	13.40
Gyre Therapeutics (GYRE)	United States	$0.753B	97.75
Jade Biosciences (JBIO)	United States	$0.730B	0.00
Astria Therapeutics (ATXS)	United States	$0.718B	0.00
BioAge Labs (BIOA)	United States	$0.715B	0.00
Kura Oncology (KURA)	United States	$0.698B	0.00
YD Bio (YDES)		$0.692B	0.00
Upstream Bio (UPB)	United States	$0.692B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.691B	0.00
EnGene Holdings (ENGN)	Canada	$0.666B	0.00
Replimune (REPL)	United States	$0.659B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Annexon (ANNX)	United States	$0.621B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.616B	0.00
Prime Medicine (PRME)	United States	$0.599B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.592B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.588B	0.00
CorMedix Inc (CRMD)	United States	$0.580B	5.37
Design Therapeutics (DSGN)	United States	$0.572B	0.00
Emergent Biosolutions (EBS)	United States	$0.570B	5.48
Neumora Therapeutics (NMRA)	United States	$0.543B	0.00
Gossamer Bio (GOSS)	United States	$0.537B	0.00
Cytek Biosciences (CTKB)	United States	$0.533B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.533B	0.00
Alto Neuroscience (ANRO)	United States	$0.511B	0.00
Keros Therapeutics (KROS)	United States	$0.506B	10.79
SELLAS Life Sciences (SLS)	United States	$0.506B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.498B	0.00
Kamada (KMDA)	Israel	$0.493B	23.81
Prothena (PRTA)	Ireland	$0.476B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.476B	0.00
Solid Biosciences (SLDB)	United States	$0.474B	0.00
PepGen (PEPG)	United States	$0.467B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.450B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.449B	0.00
Ocugen (OCGN)	United States	$0.440B	0.00
Contineum Therapeutics (CTNM)	United States	$0.434B	0.00
Tectonic Therapeutic (TECX)	United States	$0.425B	0.00
REGENXBIO (RGNX)	United States	$0.423B	0.00
Myriad Genetics (MYGN)	United States	$0.422B	0.00
PureTech Health (PRTC)	United States	$0.422B	0.00
GENFIT S.A (GNFTY)	France	$0.417B	0.00
Entrada Therapeutics (TRDA)	United States	$0.413B	0.00
Niagen Bioscience (NAGE)	United States	$0.406B	31.81
LENZ Therapeutics (LENZ)	United States	$0.406B	0.00
Prima BioMed (IMMP)	Australia	$0.404B	0.00
Zura Bio (ZURA)	United States	$0.404B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.402B	0.00
Monopar Therapeutics (MNPR)	United States	$0.396B	0.00
Immix Biopharma (IMMX)	United States	$0.393B	0.00
Verastem (VSTM)	United States	$0.390B	0.00
Benitec Biopharma (BNTC)	United States	$0.388B	0.00
Forte Biosciences (FBRX)	United States	$0.386B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.383B	0.00
NovaBridge Biosciences (NBP)	United States	$0.374B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.372B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.367B	0.00
Allogene Therapeutics (ALLO)	United States	$0.364B	0.00
Absci (ABSI)	United States	$0.364B	0.00
Anavex Life Sciences (AVXL)	United States	$0.363B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.362B	0.00
Climb Bio (CLYM)	United States	$0.359B	0.00
Invivyd (IVVD)	United States	$0.357B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.356B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.356B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.353B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.352B	0.00
Aura Biosciences (AURA)	United States	$0.350B	0.00
Puma Biotechnology (PBYI)	United States	$0.343B	9.19
Atea Pharmaceuticals (AVIR)	United States	$0.338B	0.00
Rezolute (RZLT)	United States	$0.337B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.322B	0.00
Immuneering (IMRX)	United States	$0.320B	0.00
Candel Therapeutics (CADL)	United States	$0.307B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.297B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.295B	0.00
AC Immune (ACIU)	Switzerland	$0.294B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.292B	0.00
XOMA Royalty (XOMA)	United States	$0.292B	0.00
Adherex Technologies (FENC)	United States	$0.281B	0.00
Cabaletta Bio (CABA)	United States	$0.274B	0.00
Abeona Therapeutics (ABEO)	United States	$0.270B	4.42
Nautilus Biotechnology (NAUT)	United States	$0.269B	0.00
Aardvark Therapeutics (AARD)	United States	$0.267B	0.00
Neurogene (NGNE)	United States	$0.263B	0.00
Lifecore Biomedical (LFCR)	United States	$0.262B	0.00
Palisade Bio (PALI)	United States	$0.259B	0.00
Shattuck Labs (STTK)	United States	$0.247B	0.00
Coherus Oncology (CHRS)	United States	$0.243B	0.00
Opus Genetics (IRD)	United States	$0.234B	0.00
Nuvectis Pharma (NVCT)	United States	$0.233B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.216B	0.00
Alector (ALEC)	United States	$0.207B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.206B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.204B	0.00
SAB Biotherapeutics (SABS)	United States	$0.196B	0.00
Voyager Therapeutics (VYGR)	United States	$0.190B	0.00
Humacyte (HUMA)	United States	$0.189B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.188B	0.00
C4 Therapeutics (CCCC)	United States	$0.177B	0.00
Satellos Bioscience (MSLE)	Canada	$0.174B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.169B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.169B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.168B	0.00
Sagimet Biosciences (SGMT)	United States	$0.167B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.167B	0.00
Editas Medicine (EDIT)	United States	$0.164B	0.00
Tharimmune (THAR)	United States	$0.161B	0.00
Innate Pharma S.A (IPHA)	France	$0.156B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.152B	0.00
Alps Group (ALPS)	United States	$0.150B	2.73
Starpharma Holdings (SPHRY)	Australia	$0.149B	0.00
Elicio Therapeutics (ELTX)	United States	$0.147B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.146B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.146B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Anika Therapeutics (ANIK)	United States	$0.145B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.145B	0.00
VTv Therapeutics (VTVT)	United States	$0.144B	0.00
Caribou Biosciences (CRBU)	United States	$0.142B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.142B	0.00
Nkarta (NKTX)	United States	$0.140B	0.00
Fate Therapeutics (FATE)	United States	$0.138B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.138B	0.00
Vor Biopharma (VOR)		$0.136B	0.00
Adagene (ADAG)	China	$0.134B	0.00
Spero Therapeutics (SPRO)	United States	$0.134B	0.00
Sutro Biopharma (STRO)	United States	$0.133B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.130B	0.00
Crescent Biopharma (CBIO)	United States	$0.128B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.127B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.125B	6.08
Eledon Pharmaceuticals (ELDN)	United States	$0.120B	0.00
Alpha Cognition (ACOG)	Canada	$0.115B	0.00
Repare Therapeutics (RPTX)	Canada	$0.114B	0.00
Alpha Teknova (TKNO)	United States	$0.114B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.112B	0.00
Jyong Biotech (MENS)	Taiwan	$0.112B	0.00
BGM Group (BGM)	China	$0.110B	0.00
Fortress Biotech (FBIO)	United States	$0.108B	0.00
Seer (SEER)	United States	$0.107B	0.00
Ovid Therapeutics (OVID)	United States	$0.107B	0.00
Codexis (CDXS)	United States	$0.107B	0.00
Cardiff Oncology (CRDF)	United States	$0.106B	0.00
Turn Therapeutics (TTRX)	United States	$0.106B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.105B	0.00
Immunic (IMUX)	United States	$0.105B	0.00
Citius Oncology (CTOR)	United States	$0.104B	0.00
Coya Therapeutics (COYA)	United States	$0.099B	0.00
Actuate Therapeutics (ACTU)	United States	$0.099B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.098B	0.00
Equillium (EQ)	United States	$0.097B	0.00
Agenus (AGEN)	United States	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Genelux (GNLX)	United States	$0.095B	0.00
Cognition Therapeutics (CGTX)	United States	$0.094B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.094B	0.00
BioStem Technologies (BSEM)		$0.093B	6.49
Precision BioSciences (DTIL)	United States	$0.091B	0.00
Spruce Biosciences (SPRB)	United States	$0.089B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.089B	0.00
Biomea Fusion (BMEA)	United States	$0.088B	0.00
OKYO Pharma (OKYO)		$0.088B	0.00
ATyr Pharma (ATYR)	United States	$0.087B	0.00
TuHURA Biosciences (HURA)	United States	$0.084B	0.00
EXoZymes (EXOZ)	United States	$0.084B	0.00
Tenax Therapeutics (TENX)	United States	$0.081B	0.00
BioHarvest Sciences (BHST)	Canada	$0.079B	0.00
MaxCyte (MXCT)	United States	$0.078B	0.00
MediciNova (MNOV)	United States	$0.077B	0.00
ImageneBio (IMA)	United States	$0.077B	0.00
Seres Therapeutics (MCRB)	United States	$0.074B	0.00
IBio (IBIO)	United States	$0.073B	0.00
XBiotech (XBIT)	United States	$0.072B	0.00
Scilex Holding (SCLX)	United States	$0.070B	0.00
Entera Bio (ENTX)	Israel	$0.070B	0.00
Pliant Therapeutics (PLRX)	United States	$0.069B	0.00
Annovis Bio (ANVS)	United States	$0.064B	0.00
Adicet Bio (ACET)	United States	$0.064B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.063B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.062B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.059B	0.00
InflaRx (IFRX)	Germany	$0.056B	0.00
BeyondSpring (BYSI)	United States	$0.055B	0.00
Grace Therapeutics (GRCE)	United States	$0.055B	0.00
TScan Therapeutics (TCRX)	United States	$0.053B	0.00
Instil Bio (TIL)	United States	$0.053B	0.00
MiNK Therapeutics (INKT)	United States	$0.052B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.052B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.049B	0.00
Galecto (GLTO)	Denmark	$0.048B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.048B	0.00
Q32 Bio (QTTB)	United States	$0.047B	0.00
Estrella Immunopharma (ESLA)	United States	$0.046B	0.00
NextCure (NXTC)	United States	$0.046B	0.00
Cingulate (CING)	United States	$0.046B	0.00
Kezar Life Sciences (KZR)	United States	$0.046B	0.00
Clene (CLNN)	United States	$0.045B	0.00
Aligos Therapeutics (ALGS)	United States	$0.043B	0.00
ABVC BioPharma (ABVC)	United States	$0.042B	0.00
CervoMed (CRVO)	United States	$0.042B	0.00
Elutia (ELUT)	United States	$0.041B	0.00
Xilio Therapeutics (XLO)	United States	$0.040B	0.00
Lisata Therapeutics (LSTA)	United States	$0.040B	0.00
INmune Bio (INMB)	United States	$0.039B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
Celularity (CELU)	United States	$0.035B	0.00
Pluri (PLUR)	Israel	$0.035B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.035B	0.00
RenovoRx (RNXT)	United States	$0.034B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.034B	0.00
PDS Biotechnology (PDSB)	United States	$0.033B	0.00
Jasper Therapeutics (JSPR)	United States	$0.033B	0.00
OnKure Therapeutics (OKUR)	United States	$0.033B	0.00
Oncobiologics (OTLK)	United States	$0.032B	0.00
Promis Neurosciences (PMN)	Canada	$0.032B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.032B	2.04
Werewolf Therapeutics (HOWL)	United States	$0.032B	0.00
TELA Bio (TELA)	United States	$0.032B	0.00
Hyperion DeFi (HYPD)	United States	$0.032B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Rein Therapeutics (RNTX)	United States	$0.031B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.030B	0.00
Lantern Pharma (LTRN)	United States	$0.030B	0.00
Dyadic (DYAI)	United States	$0.030B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.030B	0.00
AN2 Therapeutics (ANTX)	United States	$0.029B	0.00
Femasys (FEMY)	United States	$0.029B	0.00
Passage Bio (PASG)	United States	$0.028B	0.00
Exicure (XCUR)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
IO Biotech (IOBT)	Denmark	$0.026B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.026B	0.00
Medicus Pharma (MDCX)	United States	$0.025B	0.00
Boundless Bio (BOLD)	United States	$0.025B	0.00
Rallybio (RLYB)	United States	$0.025B	0.00
Dare Bioscience (DARE)	United States	$0.024B	0.00
Cue Biopharma (CUE)	United States	$0.024B	0.00
Aytu BioPharma (AYTU)	United States	$0.023B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.023B	0.00
Skye Bioscience (SKYE)	United States	$0.023B	0.00
Intensity Therapeutics (INTS)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.022B	0.00
Senti Biosciences (SNTI)	United States	$0.021B	0.00
Apollomics (APLM)	United States	$0.021B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.020B	0.00
LeonaBio (LONA)	United States	$0.018B	0.00
IN8bio (INAB)	United States	$0.018B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.017B	0.00
FibroBiologics (FBLG)	United States	$0.016B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.016B	0.00
Black Titan (BTTC)	United States	$0.016B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.015B	0.00
Hoth Therapeutics (HOTH)	United States	$0.015B	0.00
Curis (CRIS)	United States	$0.015B	0.00
Polyrizon (PLRZ)	Israel	$0.015B	0.00
Applied Therapeutics (APLT)	United States	$0.014B	0.00
Quantum Biopharma (QNTM)	Canada	$0.014B	0.00
Allarity Therapeutics (ALLR)	United States	$0.014B	0.00
Cocrystal Pharma (COCP)	United States	$0.013B	0.00
NewcelX (NCEL)	Switzerland	$0.013B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.013B	0.00
Quince Therapeutics (QNCX)	United States	$0.013B	0.00
BioCardia (BCDA)	United States	$0.012B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.011B	0.00
Longeveron (LGVN)	United States	$0.011B	0.00
Bionano Genomics (BNGO)	United States	$0.011B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.011B	0.00
Soligenix (SNGX)	United States	$0.011B	0.00
BioAtla (BCAB)	United States	$0.010B	0.00
CalciMedica (CALC)	United States	$0.010B	0.00
Revelation Biosciences (REVB)	United States	$0.010B	0.00
Imunon (IMNN)	United States	$0.010B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.009B	0.00
Biofrontera (BFRI)	United States	$0.009B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.009B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.009B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.009B	0.00
Novogen (KZIA)	Australia	$0.009B	0.00
Edesa Biotech (EDSA)	Canada	$0.008B	0.00
Beyond Air (XAIR)	United States	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.007B	0.00
Gelteq (GELS)	Australia	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
Mainz Biomed (MYNZ)	Germany	$0.007B	0.00
Mustang Bio (MBIO)	United States	$0.007B	0.00
Aptevo Therapeutics (APVO)	United States	$0.007B	0.00
GENPREX (GNPX)	United States	$0.006B	0.00
Alzamend Neuro (ALZN)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
IMMURON (IMRN)	Australia	$0.006B	0.00
Advanced Biomed (ADVB)	United States	$0.005B	0.00
Evogene (EVGN)	Israel	$0.005B	0.00
GT Biopharma (GTBP)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
BioAffinity Technologies (BIAF)	United States	$0.005B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.005B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Aprea Therapeutics (APRE)	United States	$0.004B	0.00
GeoVax Labs (GOVX)	United States	$0.004B	0.00
Silo Pharma (SILO)	United States	$0.004B	0.00
Dermata Therapeutics (DRMA)	United States	$0.004B	0.00
MetaVia (MTVA)	United States	$0.004B	0.00
Avalon GloboCare (ALBT)	United States	$0.004B	0.00
KALA BIO (KALA)	United States	$0.004B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.004B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.003B	0.00
AquaBounty Technologies (AQB)	United States	$0.003B	0.00
GRI Bio (GRI)	United States	$0.003B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Psyence Biomedical (PBM)	Canada	$0.003B	0.00
Enveric Biosciences (ENVB)	United States	$0.003B	0.00
HCW Biologics (HCWB)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.002B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.002B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.002B	0.00
Abpro Holdings (ABP)	United States	$0.002B	0.00
Bone Biologics (BBLG)	United States	$0.002B	0.00
Biorestorative Therapies (BRTX)	United States	$0.002B	0.00
Onconetix (ONCO)	United States	$0.002B	0.00
Ensysce Biosciences (ENSC)	United States	$0.002B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Compugen (CGEN)	Israel	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pharvaris (PHVS)	Netherlands	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00